Natural and molecular history of prolactinoma: insights from a<i>Prlr</i>-/– mouse model
Valérie Bernard, Nadine Binart(Inserm), Chiara Villa(Centre National de la Recherche Scientifique), Sophie Lamothe(Inserm), Jacques Young(Inserm), Sandrine Caburet(Centre National de la Recherche Scientifique), Aurélie Auguste(Veracyte (United States)), A. Martin(Centre National de la Recherche Scientifique), Anne Guillou(Centre National de la Recherche Scientifique), Reiner A. Veitia(Centre National de la Recherche Scientifique)
Cited by 22
Related Papers
European Consensus Statement on congenital hypogonadotropic hypogonadism—pathogenesis, diagnosis and treatment
|Nature Reviews Endocrinology|2015|860
SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas
|Nature Genetics|2015|375
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study
|The Journal of Clinical Endocrinology & Metabolism|2010|374
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
|Endocrine Related Cancer|2017|357
Gigantism and Acromegaly Due to Xq26 Microduplications and <i>GPR101</i> Mutation
|New England Journal of Medicine|2014|340